Natural Products Journal, a leading publication by Bentham Science Publishers, primarily focuses on the rapidly evolving field of Natural Products and their applications in Complementary and Alternative Medicine as well as Drug Discovery. With an ISSN of 2210-3155 and an E-ISSN of 2210-3163, this journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the critical role of natural compounds in health and medicine. Since its inception in 2011, it has consolidated its reputation, achieving a Q3 ranking in Complementary and Alternative Medicine and a Q4 ranking in Drug Discovery as of 2023, illustrating its growing influence within the academic community. Although it currently does not operate as an Open Access journal, it remains a vital resource for cutting-edge research and developments in natural products, offering insightful contributions that pave the way for innovative therapeutic strategies. Located in the Netherlands, the journal is pivotal for those looking to stay at the forefront of research in natural substances and their multifaceted applications.

JOURNAL OF NATURAL PRODUCTS, published by the American Chemical Society, is a premier academic journal that focuses on the study and application of natural products in various scientific domains. With an esteemed ISSN of 0163-3864 and an E-ISSN of 1520-6025, this journal caters to a wide range of fields, including Analytical Chemistry, Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, Pharmaceutical Science, and Pharmacology. The journal consistently ranks in the Q1 and Q2 quartiles across these categories, reflecting its significant contribution and rigorous standards in the scientific community. Notably, its Scopus rankings highlight its influence, with notable percentiles across various fields, including a 93rd percentile in Complementary and Alternative Medicine. The JOURNAL OF NATURAL PRODUCTS aims to advance knowledge in the field by publishing groundbreaking research articles, reviews, and critical insights, making it an essential resource for researchers, professionals, and students dedicated to exploring the vast potential of natural substances. This journal addresses complex challenges and fosters innovative developments, further establishing its place as a cornerstone in natural products research. Access to published articles may vary, underscoring the need for individuals in this field to stay connected with the latest advances through the journal's offerings.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

The Journal of Ethnopharmacology, published by Elsevier Ireland Ltd, is a pivotal resource in the fields of Drug Discovery and Pharmacology, recognized as a Q1 journal in both categories as of 2023. With a rich history since its inception in 1979, this peer-reviewed journal provides a platform for rigorous research and innovative findings related to traditional medicinal practices and the therapeutic potential of natural products. The journal is ISSN 0378-8741 and E-ISSN 1872-7573, and it plays a vital role in advancing knowledge through its high-quality publications, which rank impressively at #35 out of 313 in Pharmacology and #19 out of 157 in Drug Discovery according to Scopus metrics. Although not open access, the journal aims to cater to a diverse audience of researchers, professionals, and students dedicated to exploring the intersection of ethnopharmacology and modern scientific inquiry. Its comprehensive scope encapsulates a multitude of studies spanning the globe, fostering a deeper understanding of how traditional practices can inform contemporary health solutions.

The Journal of Herbal Medicine, published by Elsevier GmbH in Germany, stands at the forefront of research in the dynamic and evolving field of complementary and alternative medicine. With an ISSN of 2210-8033 and an E-ISSN of 2210-8041, this journal has been contributing significant insights since its inception in 2011 and continues to be a vital resource through 2024. Recognized for its scholarly rigor, it holds a commendable Q2 ranking in the 2023 Scopus category for Complementary and Alternative Medicine, placing it in the upper echelons of its field with a rank of 32 out of 105 journals, marking it in the 70th percentile. The Journal of Herbal Medicine emphasizes the integration of traditional herbal therapies and modern scientific approaches, offering researchers, professionals, and students a platform for disseminating their findings and fostering an inclusive dialogue on natural medicine's role in healthcare. Although it is not an open-access publication, its commitment to high-quality research makes it an essential read for those wanting to explore the efficacy and application of herbal medicine in contemporary practice.

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

International Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.

Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy, published by SpringerNature, stands at the forefront of scientific exploration in the field of pharmacology, toxicology, and pharmaceutics. With an impressive Q2 ranking in the 2023 category concerning miscellaneous pharmacological sciences and a commendable Scopus rank of #30 out of 80, this journal serves as a crucial platform for disseminating innovative research and advancements in pharmacognosy. The journal, which has been a vital part of the academic landscape since 2007, seeks to facilitate open access to knowledge for researchers, professionals, and students, thereby fostering a collaborative community dedicated to enhancing understanding of medicinal resources and their applications. Through rigorous peer review and a commitment to quality, the Brazilian Journal of Pharmacognosy aims to advance the frontiers of pharmaceutical sciences and promote the sustainable use of natural products in Brazil and beyond.

Research Journal of Pharmacognosy, published by the Iranian Society of Pharmacognosy, is a pioneering forum for the dissemination of research in the field of pharmacognosy and its related disciplines. Founded in 2014 as an Open Access journal, it aims to provide swift and free access to high-quality research articles, fostering collaboration and innovation among researchers, professionals, and students. Operating from Tehran, Iran, this journal addresses a wide range of topics including complementary and alternative medicine, drug discovery, and organic chemistry, making it an invaluable resource for those researching the extraction, characterization, and application of naturally derived compounds. The journal holds a Category Quartile ranking of Q3 in Complementary and Alternative Medicine and Q4 in both Drug Discovery and Organic Chemistry for the year 2023, which underscores its growing influence within the scientific community. By serving as a platform for current advances and thought leadership in pharmacognosy, the Research Journal of Pharmacognosy plays a crucial role in bridging the gap between traditional practices and modern pharmacological applications.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.